Homepage
Open in app
Sign in
Get started
Mubadala Capital — Ventures
We partner with visionary founders building enduring technology companies, and support them with Mubadala’s global scale, resources and capital.
Follow
Metsera: Pioneering the Future of Obesity Therapeutics
Metsera: Pioneering the Future of Obesity Therapeutics
For over seven years, our healthcare team has been expanding our ventures business, supporting companies that are revolutionizing…
Alaa Halawa
Apr 18
The Two Seismic Tech Shifts That Will Change Our World
The Two Seismic Tech Shifts That Will Change Our World
The world is rapidly moving towards two seismic shifts in science and technology that will disrupt economies, change entire industries and…
Rafic Makki
Feb 6
The next frontier of precision medicine — editing the epigenome
The next frontier of precision medicine — editing the epigenome
Gene editing has taken the biotech world by storm since the initial discovery of CRISPR-Cas9, which holds the promise of a potential…
Amy Liu
Jul 27, 2023
The Future of Medicine: AI-Designed Drugs and the Race for FDA Approval
The Future of Medicine: AI-Designed Drugs and the Race for FDA Appr...
The chemical exploration space for drug design is astronomical, estimated at more than 10 exp(20)–10 exp(24) molecules of up to 30 atoms…
Rafic Makki
Jul 26, 2023
Building EpiBiologics: Mubadala’s company creation strategy
Building EpiBiologics: Mubadala’s company creation strategy
By Alaa Halawa and Amy Liu
Amy Liu
Mar 22, 2023
Shifting the Clinical Research Paradigm
Shifting the Clinical Research Paradigm
A discussion with Kent Thoelke, CEO of Paradigm, on our most recent investment in clinical trial transformation
Alaa Halawa
Jan 30, 2023
Technology Megatrends in the Age of Hyperscale Innovation
Technology Megatrends in the Age of Hyperscale Innovation
Science and Technology Breakthroughs in 2022
Rafic Makki
Jan 23, 2023
Latest
Vevo Therapeutics – Improving Drug Dicovery with In Vivo Data and AI
Vevo Therapeutics – Improving Drug Dicovery with In Vivo Data and AI
Despite significant advances in the biotechnology industry over the past years, clinical trials continue to face a high rate of failure…
Ayman Alabdallah
Dec 8, 2022
A bridge to Web3 — and why we invested in Ramp Network
A bridge to Web3 — and why we invested in Ramp Network
I’m a passionate believer in Web3. My first investment in blockchain was in 2013 — the same year Alan Greenspan referred to Bitcoin as “a…
Frederic Lardieg
Nov 9, 2022
Our Investment in Pretzel Therapeutics: Creating a Powerhouse in the Mitochondria Field
Our Investment in Pretzel Therapeutics: Creating a Powerhouse in the Mitochondria Field
As the “powerhouse of the cell,” mitochondria play a critical role in cell viability through a multitude of functions — from energy…
Alaa Halawa
Sep 12, 2022
About MubadalaVentures
Latest Stories
Archive
About Medium
Terms
Privacy
Teams